The ROE as of December 2025 (TTM) for ZyVersa Therapeutics, Inc. (ZVSA) is 677.15%

According to ZyVersa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 677.15%. This represents a change of 2.97% compared to the average of 22.05% of the last 4 quarters.

ZyVersa Therapeutics, Inc. (ZVSA) Historical ROE (quarterly & annually)

How has ZVSA ROE performed in the past?

The mean historical ROE of ZyVersa Therapeutics, Inc. over the last ten years is -22244.24%. The current 677.15% ROE has changed -103.04% with respect to the historical average. Over the past ten years (40 quarters), ZVSA's ROE was at its highest in in the March 2021 quarter at 24.08%. The ROE was at its lowest in in the June 2021 quarter at -10387.90%.

ZyVersa Therapeutics, Inc. (ZVSA) ROE by Quarter and Year

Discovering the peaks and valleys of ZyVersa Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ZyVersa Therapeutics, Inc. (ZVSA) Average ROE

How has ZVSA ROE performed in the past?

The current ROE of ZyVersa Therapeutics, Inc. (ZVSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ZyVersa Therapeutics, Inc. (ZVSA) ROE vs. Peers

How is ZVSA’s ROE compared to its peers?

ZyVersa Therapeutics, Inc.’s ROE is greater than Hepion Pharmaceuticals, Inc. (-1000.33%), greater than CDT Equity Inc. (-2194.54%), greater than Enveric Biosciences, Inc. (-341.49%), less than Longevity Health Holdings Inc. (141.35%), greater than NewGenIvf Group Limited (3.44%), greater than SCWorx Corp. (-72.27%), greater than Indaptus Therapeutics, Inc. (-612.63%), greater than Jasper Therapeutics, Inc. (-121.65%), greater than Onconetix, Inc. (-839.59%), less than Silexion Therapeutics Ltd. (1.22%),

Build a custom stock screener for ZyVersa Therapeutics, Inc. (ZVSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZyVersa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ZyVersa Therapeutics, Inc. (ZVSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ZyVersa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.